TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
DrugtestScandinavia AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,918
|
2,801
|
2,334 |
| Financial expenses |
0
|
0
|
28 |
| Earnings before taxes |
-599
|
-312
|
-23 |
| EBITDA |
-600
|
-321
|
4 |
| Total assets |
840
|
1,336
|
1,917 |
| Current assets |
840
|
1,336
|
1,657 |
| Current liabilities |
1,334
|
1,231
|
811 |
| Equity capital |
-494
|
105
|
1,106 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-58.8%
|
7.9%
|
57.7% |
| Turnover per employee |
2,918
|
1,400
|
1,167 |
| Profit as a percentage of turnover |
-20.5%
|
-11.1%
|
-1.0% |
| Return on assets (ROA) |
-71.3%
|
-23.4%
|
0.3% |
| Current ratio |
63.0%
|
108.5%
|
204.3% |
| Return on equity (ROE) |
121.3%
|
-297.1%
|
-2.1% |
| Change turnover |
117
|
467
|
595 |
| Change turnover % |
4%
|
20%
|
34% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.